Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Biochim Biophys Acta 1991 Jun 07;10931:87-94. doi: 10.1016/0167-4889(91)90142-k.
Show Gene links Show Anatomy links

Erbstatin and tyrphostins block protein-serine kinase activation and meiotic maturation of sea star oocytes.

Daya-Makin M , Pelech SL , Levitzki A , Hudson AT .

The effects of ten putative protein-tyrosine kinase inhibitors on the activation of protein-serine kinases and germinal vesicle breakdown (GVBD) in maturing sea star oocytes were investigated. Erbstatin and tyrphostins such as AG18 and AG125 blocked 1-methyladenine-induced GVBD in sea star oocytes with IC50 values of less than 20 microM. Inhibition of the rate of GBVD was achieved even when these compounds were added up to 15 min after exposure of the oocytes to 1-methyladenine. The action of these substances on oocyte maturation was reversed by subsequent washing and culturing of the cells in natural sea water free of the inhibitors. Cell viability was maintained for at least 12 h in their presence, as assessed by Trypan blue dye exclusion. These inhibitors prevented the 1-methyladenine-induced activations of the histone H1 kinase p34cdc2, the myelin basic protein kinase p44mpk and a ribosomal S6 peptide kinase. Erbstatin, AG18 and AG125 prevented 1-methyladenine-induced tyrosine dephosphorylation of p34cdc2, and they inhibited tyrosine phosphorylation of p44mpk. These studies imply that activation of a protein-tyrosine kinase may be necessary for stimulation of p34cdc2 in maturing sea star oocytes.

PubMed ID: 1828701
Article link: Biochim Biophys Acta

Genes referenced: LOC100887844 LOC115919910 LOC586799